Differentiating large cell lymphoma from indolent small B-cell lymphoma in fine needle aspirates using p53, PCNA and transformed lymphocyte count

Acta Cytologica

Volumn 44, Issue 4, 2000, Pages 592-603

  Young, N A ^a   Ehya, H ^a   Klein Szanto, A ^a   Litwin, S ^a   Smith, M R ^a   Al Saleem, T ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Aspiration biopsy; B cell lymphoma; Lymphocyte count; Lymphoma, large cell; p53 Protein; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; PROTEIN P53;

ARTICLE; ASPIRATION CYTOLOGY; B CELL LYMPHOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOARCHITECTURE; DIAGNOSTIC TEST; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; LYMPHOCYTOMA; NEEDLE BIOPSY; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

EID: 0033890744     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000328534     Document Type: Article

References (32)

1. Utilization of fine needle aspiration cytology and flow cytometry in the diagnosis and subclassification of primary and recurrent lymphoma
2. The value of transformed lymphocyte count in subclassification of Non Hodgkin's lymphoma by fine needle aspiration
3. The role of FNA cytology in the diagnosis of lymphoma
4. Cytomorphologic, immunocytochemical, and nucleic acid flow cytometric study of 50 lymph nodes by fine-needle aspiration: Comparison with results obtained by subsequent excisional biopsy
5. Combining fine-needle aspiration and flow cytometric immunophenotyping in evaluation of nodal and extranodal sites for possible lymphoma: A retrospective review
6. Diagnosis of mantle cell lymphoma on tissue acquired by fine needle aspiration in conjunction with immunocytochemistry and cytokinetic studies: Possibilities and limitations
7. The potential clinical impact of the fine needle aspiration/flow cytometric diagnosis of malignant lymphoma
8. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
9. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: A progress report
10. The Non-Hodgkin's Lymphoma Pathologic Classification Project Committee: National Cancer Institute sponsored study of classification of non-Hodgkin's lymphoma: Summary and description of a working formulation for clinical usage
11. The Advanced Theory of Statistics
12. The use of confidence or fiducial limits illustrated in the case of the binomial
13. Structure and function of p53 in normal cells and their aberrations in cancer cells: Projection on the hematologic cell lineages
14. Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma
15. Transformation of follicular lymphoma: Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation
16. p53 Mutation is associated with progression in follicular lymphomas
17. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma
18. p53 Mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis
19. Cyclin/PCNA is the auxiliary protein of DNA polymerasedelta
20. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues
21. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma
22. Estimation of growth fraction in fine needle aspirates from non-Hodgkin's lymphoma using anti-proliferating cell nuclear antigen: Correlation with the Kiel classification
23. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors
24. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in archival samples of non-Hodgkin's lymphoma: Correlation with flow cytometry proliferation results (lett)
25. p53 In tumor pathology: Can we trust immunohistochemistry?
26. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas
27. MYC rearrangements in histologically progressed follicular lymphomas
28. p53 Immunohistochemistry: A word of caution (edit)
29. Comparison of p53 immunoreactivity in fresh-cut versus stored slides with and without microwave heating
30. Tumor pathology: Can we trust immunohistochemistry?: Revisited
31. High levels of p53 protein in UV irradiated normal human skin
32. Is immunolocalization of proliferating cell nuclear antigen (PCNA) in paraffin sections a valid index of cell proliferation?